Contribute Try STAT+ Today

A federal judge has blocked a Trump administration policy that reduces payments to hospitals under a drug discount program, ruling Thursday that the government overstepped its authority in an attempt to address the high cost of prescription medications.

The decision is a win for the 2,000-plus hospitals participating in the program, known as 340B, most of which serve large numbers of low-income patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • The inequity between “low income” and those on Social Security deciding between good and prescriptions is appalling! We have young healthy people who NEVER worked and don’t WANT to work getting FREE prescriptions on Medicaid while seniors struggle to carry additional prescription insurance with monthly premiums, high deductibles, high co pays and limited formulates!!!

  • /healthpayerintelligence


  • Case in point!

    2.5 Billion. That’s B for Billion in false claims recovered and mainly at the hospital level.

  • If institutions had not mis appropriated 340B discounts to NON 340B qualified patients then this situation wouldn’t have evolved the way it did. It’s that simple.

    There were some pretty well known medical institutions who WERE the profit leeches.

  • To attempt to reduce the 340B support to hospitals that serve low-income patients is tantamount to outright ignorance for those in the health care industry who are not for-profit-leeches. Good for this Judge to force the HHS to look elsewhere (into deeper pockets) for drug pricing cuts !

Comments are closed.